Schnieders Capital Management LLC Abbott Laboratories Transaction History

Schnieders Capital Management LLC

$499 Million
Q4 2024

A detailed history of Schnieders Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Schnieders Capital Management LLC holds 51,333 shares of ABT stock, worth $6.93 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

51,333

Previous 51,593 0.5%

Holding current value

$6.93 Million

Previous $5.88 Million 1.29%

% of portfolio

1.16%

Previous 1.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 04, 2025	SELL	$111.93 - $119.39 $29,101 - $31,041	-260 Reduced 0.5%	51,333 $5.81 Million
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $51,536 - $60,836	515 Added 1.01%	51,593 $5.88 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $166,204 - $185,526	-1,650 Reduced 3.13%	51,078 $5.31 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $5,476 - $6,048	-50 Reduced 0.09%	52,728 $5.99 Million
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $1.6 Million - $1.96 Million	-17,738 Reduced 25.15%	52,778 $5.81 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $1.59 Million - $1.91 Million	-16,652 Reduced 19.1%	70,516 $6.83 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $43,940 - $48,958	-436 Reduced 0.5%	87,168 $9.5 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $77,488 - $91,208	800 Added 0.92%	87,604 $8.87 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $413,606 - $485,223	4,351 Added 5.28%	86,804 $9.53 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $1.05 Million - $1.21 Million	10,839 Added 15.14%	82,453 $7.98 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $122,892 - $148,537	-1,204 Reduced 1.65%	71,614 $7.78 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $58,720 - $71,605	-515 Reduced 0.7%	72,818 $8.62 Million
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $149,264 - $182,766	1,292 Added 1.79%	73,333 $10.3 Million
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $29,748 - $32,910	-255 Reduced 0.35%	72,041 $8.51 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $6,770 - $7,969	64 Added 0.09%	72,296 $8.38 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $58,773 - $69,244	540 Added 0.75%	72,232 $8.66 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $24,675 - $26,888	235 Added 0.33%	71,692 $7.85 Million
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $34,090 - $41,399	-372 Reduced 0.52%	71,457 $7.78 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $1,914 - $2,450	25 Added 0.03%	71,829 $6.57 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $18,092 - $26,455	288 Added 0.4%	71,804 $5.67 Million
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $151,916 - $169,119	1,935 Added 2.78%	71,516 $6.21 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $33,718 - $36,560	412 Added 0.6%	69,581 $5.82 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $8,526 - $9,945	-117 Reduced 0.17%	69,169 $5.82 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $54,631 - $66,049	-825 Reduced 1.18%	69,286 $5.54 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $34,419 - $38,991	-525 Reduced 0.74%	70,111 $5.07 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $9,121 - $11,004	150 Added 0.21%	70,636 $5.18 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $28,209 - $31,134	-490 Reduced 0.69%	70,486 $4.3 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $13,392 - $15,141	-238 Reduced 0.33%	70,976 $4.25 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $10,736 - $11,494	200 Added 0.28%	71,214 $4.06 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $3.41 Million - $3.81 Million	71,014	71,014 $3.79 Million

Others Institutions Holding ABT

# of Institutions

3,372

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $237B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schnieders Capital Management LLC with notifications on news.

Account

Schnieders Capital Management LLC Abbott Laboratories Transaction History